BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36453356)

  • 41. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Monocanalicular silicone stent implantation in children with congenital nasolacrimal duct obstruction].
    Szalai I; Maneschg OA; Nagy ZZ
    Orv Hetil; 2020 Nov; 161(48):2037-2042. PubMed ID: 33249409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monocanalicular versus bicanalicular intubation in external dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction.
    Saleh GM; Tossounis CM; Litwin AS; Gauba V; Samaras K; McLean CJ
    Orbit; 2009; 28(2-3):110-4. PubMed ID: 19839894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasolacrimal duct screening to minimize post-cataract surgery endophthalmitis.
    Kam JK; Cheng NM; Sarossy M; Allen PJ; Brooks AM
    Clin Exp Ophthalmol; 2014 Jul; 42(5):447-51. PubMed ID: 24118663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transection of Nasolacrimal Duct in Endoscopic Medial Maxillectomy: Implication on Epiphora.
    Imre A; Imre SS; Pinar E; Ozkul Y; Songu M; Ece AA; Aladag I
    J Craniofac Surg; 2015 Oct; 26(7):e616-9. PubMed ID: 26468843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A glued technique of external dacryocystorhinostomy.
    Rizvi SAR; Sabah M; Mehmood F; Maheshwari R; Alam MS
    Indian J Ophthalmol; 2022 Mar; 70(3):962-964. PubMed ID: 35225551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nasolacrimal Duct Management During Endoscopic Sinus and Skull Base Surgery.
    Rotsides JM; Franco A; Albader A; Casiano RR; Lieberman SM
    Ann Otol Rhinol Laryngol; 2019 Oct; 128(10):932-937. PubMed ID: 31088142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple and efficient technique for suturing and knotting during endoscopic dacryocystorhinostomy.
    Chen R; Liu S; Jiang A; Wumaier A; Yang Y; Yu X; Meng Z; Mao Y; Liang X
    Int Ophthalmol; 2023 Jan; 43(1):63-71. PubMed ID: 35838862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of topical steroids on recently developed incomplete nasolacrimal duct obstruction: optical coherence tomography study.
    Yang MK; Kim N; Choung HK; In Khwarg S
    Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2315-2322. PubMed ID: 31342147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children.
    Cui YH; Zhang CY; Liu W; Wu Q; Yu G; Li L; Wei WB
    BMC Ophthalmol; 2019 Dec; 19(1):244. PubMed ID: 31796021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of patient-reported outcome and quality of life improvement following surgery for epiphora.
    Sipkova Z; Vonica O; Olurin O; Obi EE; Pearson AR
    Eye (Lond); 2017 Dec; 31(12):1664-1671. PubMed ID: 28622317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resolution of recalcitrant chronic papillary conjunctivitis associated with epiphora following punctoplasty and lacrimal stenting.
    Gabbay IE; Nahum Y; Yassur Y; Avisar I
    Can J Ophthalmol; 2018 Aug; 53(4):380-383. PubMed ID: 30119793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoscopic-assisted probing for congenital nasolacrimal duct obstruction.
    Wallace EJ; Cox A; White P; Macewen CJ
    Eye (Lond); 2006 Sep; 20(9):998-1003. PubMed ID: 16138115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoscopic dacryocystorhinostomy as an option for symptomatic epiphora in isolated monocanalicular obstruction.
    Mueller AJ; Scofield-Kaplan SM; Tenzel PA; Winward B; Clair BC; Mancini R
    Orbit; 2021 Oct; 40(5):419-422. PubMed ID: 32715905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A novel retrograde intubation procedure for treatment of nasolacrimal duct obstruction].
    Zhang JX; Deng HW; Yan B; Yin H; Huang YT; Liao SH; Jiang LJ
    Zhonghua Yan Ke Za Zhi; 2007 Sep; 43(9):806-9. PubMed ID: 18070526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dacryocystoplasty: treatment of epiphora by means of balloon dilation of the obstructed nasolacrimal duct system.
    Janssen AG; Mansour K; Krabbe GJ; van der Veen S; Helder AH
    Radiology; 1994 Nov; 193(2):453-6. PubMed ID: 7972762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Evolving Story of CNLDO: Serial Photographic Documentation and Parental Perspectives.
    Singh S; Ali MJ
    Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):88-91. PubMed ID: 35829659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating the outcomes of children undergoing lacrimal surgery for congenital nasolacrimal duct obstruction with the aim of developing a patient pathway for children presenting to a tertiary paedatric service with epiphora.
    Sooby P; Wynne D
    J Laryngol Otol; 2023 Jul; 137(7):815-819. PubMed ID: 36815293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.